Revlimid in Transfusion Dependent Patients
NCT01178814
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
57
Enrollment
OTHER
Sponsor class
Conditions
Myelodysplastic Syndrome
Interventions
DRUG:
Revlimid (Lenalidomide)
Sponsor
Columbia University
Collaborators
[object Object]